|
Market Research Report
European Biomarker Analysis Market
| Published by |
Frost & Sullivan |
| Published |
September, 2009 |
Product code |
100966 |
| Content info |
107 Pages |
| Price |
|
|
European Biomarker Analysis Market published by Frost & Sullivan in September, 2009. This report consists of 107 Pages and the price starts from US $ 6500.
Abstract
This research service gives a detailed analysis of the biomarker analysis
market in Europe from 2005-2015.
Table of Contents
1. EXECUTIVE SUMMARY
Overview of the European Biomarker Analysis Market
- 1. Executive Summary of the European Biomarker Analysis Market
2. EXCHANGE RATES AND GLOSSARY OF TERMS
Glossary of Terms and Exchange Rates
- 1. Definitions
- 2. Exchange Rates
3. INDUSTRY CHALLENGES
Challenges Faced by the European Biomarker Analysis Industry
- 1. Industry Challenges for the European Biomarker Analysis Market
4. TOTAL EUROPEAN BIOMARKER ANALYSIS MARKET
Total Biomarker Analysis Market - Europe
- 1. Multi-parametric analysis of Companies in the Biomarker Space
- 2. Introduction
- 3. Market Overview
- 4. Scope of the Research
- 5. Research Methodology
- 6. Measurements
- 7. Stakeholder Implications
- 8. Market Drivers
- 9. Market Restraints
- 10. Revenue Forecasts
- 11. Competitive Structure
- 12. Global Biomarker Initiatives: Present and Future Directions
- 13. Analysis of Biomarker Thrust Areas by Disease
- 14. Key Alliances in the Biomarker Space
Competitive analysis of Biomarker Companies
- 1. Analysis of Opportunities and Market Attractiveness by Segment
- 2. Bioinformatics Companies in the Biomarkers Market
- 3. Assessment of the Theranostics Ambit
- 4. Analysis of Market Opportunities for CROs in the Biomarkers Market
- 5. Analysis of Market Attractiveness by Geographical Region
5. MARKET ENGINEERING STRATEGIC RECOMMENDATIONS
Strategic Recommendations
- 1. Strategic Recommendations for the European Biomarker Analysis Market
6. DATABASE OF KEY INDUSTRY PARTICIPANTS
Key Industry Participants
- 1. List of Key Industry Participants
7. DECISION SUPPORT DATABASE
Decision Support Databases for the European Biomarker Analysis Market
- 1. Government Healthcare Expenditure
- 2. Pharmaceutical R&D Expenditure
- 3. Per cent Pharmaceutical R&D Expenditure
- 4. Government Biotechnology R&D Expenditure
- 5. Private Healthcare Expenditure
|
